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a b s t r a c t
A series of binuclear palladium(II) salicylaldiminato dithiosemicarbazone complexes have been synthe-
sized and characterized. The palladium complexes were obtained by the reaction of various ethylene-
and phenylene-bridged dithiosemicarbazones with Pd(PPh3)2Cl2. The free salicylaldimine ligands and
their palladium complexes were characterized by NMR and IR spectroscopies, ESI-mass spectrometry,
elemental analyses and for two representative complexes also by X-ray diffraction. In both metal com-
plexes, the solid-state structures show the two palladium centers to be coordinated in a slightly distorted
square-planar geometry, which gives rise in each case to ﬁve- and six-membered chelate rings. The sal-
icylaldimine thiosemicarbazone ligands coordinate to palladium in a tridentate manner, through the phe-
nolic oxygen, imine nitrogen and thiolate sulfur atoms.
1. Introduction
In view of the wide spectrum of biological applications of thio-
semicarbazones [1–4], including activity against diseases such as
TB [5], leprosy [6], malaria [7,8], as well as a range of bacterial
infections [9–13], the chemistry of thiosemicarbazones and their
metal complexes has attracted proliﬁc attention over the past dec-
ade [2,14–16]. Thiosemicarbazones belong to a class of com-
pounds, grouped together with Schiff bases, containing sulfur and
nitrogen donor atoms that can bond to electron-deﬁcient metals.
Selected metal complexes of thiosemicarbazones were found to
display enhanced biological activity over the uncomplexed thio-
semicarbazones [17,18].
Dithiosemicarbazones and bis(thiosemicarbazones) are dimeric
structures generally containing two thiosemicarbazone moieties.
Dithiosemicarbazones, a term used by Swearingen and West [19]
to differentiate between bis(thiosemicarbazones) and dithiosemic-
arbazones, consist of two mono-thiosemicarbazone moieties con-
nected by their amide nitrogen atoms to an aliphatic or aromatic
spacer (Fig. 1). Bis(thiosemicarbazones) also consist of two mono-
meric thiosemicarbazone moieties, however, linked through their
imine nitrogen atoms to a hydrocarbon spacer (Fig. 1).
There are few reports available on transitionmetal complexes of
dithiosemicarbazones. Wiles et al. synthesized one of the ﬁrst
transition metal-containing dithiosemicarbazones, linked by an
ethylene bridge [20]. The biological properties of these copper com-
plexes were investigated and displayed antifungal activity against
the cellulolytic microorganism, Chaetomium globosum. Examples
of analogous dithiosemicarbazones have been successfully synthe-
sized containing ethylene, phenylene and piperazine bridges. These
dithiosemicarbazones have incorporated transition metals from
group 4 (Ti, Zr) [21], group 9 (Co) [19], group 10 (Ni) [19,22], group
11 (Cu) [19,20], group 12 (Zn) elements [23], and the lanthanides
(La, Pr) [24]. It is noteworthy that platinum group metal complexes
of dithiosemicarbazones are sparse, given that platinum and palla-
dium complexes of heterocyclic thiosemicarbazones show signiﬁ-
cant anticancer activity [25]. As part of our continuing interest in
the synthesis of transitionmetal complexes of biological molecules,
we have investigated the coordination behaviour of dithiosemicar-
bazones towards palladium(II), with a view to develop new transi-
tion metal pharmaceuticals. This paper describes the synthesis,
structural characterization and preliminary biological activity of
salicylaldimine dithiosemicarbazone ligands and their complexa-
tion with palladium(II) to form binuclear complexes.
2. Experimental
2.1. General experimental procedures
All reagents and solvents were purchased from commercial
sources (Sigma–Aldrich, Fluka, Merck, Kimix) and used as received.
* Corresponding author. Tel.: +27 (0)21 650 5279; fax: +27 (0)21 689 7499.
E-mail address: gregory.smith@uct.ac.za (G.S. Smith).
, , ,
Published in Polyhedron 28, issue 14, 2839-2846, 2009
which should be used for any reference to this work
1
Palladium dichloride was received as a donation from Anglo Plati-
num. Ethane-1,2-dithiosemicarbazide [26], benzene-1,4-dithiose-
micarbazide [23], and Pd(PPh3)2Cl2 [27] were prepared following
reported literature procedures. Solvents were freshly distilled
and dried over the appropriate drying agents.
2.2. Instrumentation
Nuclear magnetic resonance (NMR) spectra were recorded on
either a Varian Mercury XR300 MHz spectrometer (1H at
300.08 MHz, 13C at 75.46 MHz, 31P at 121.47 MHz) or a Varian
Unity XR400 MHz spectrometer (1H at 399.95 MHz, 13C at
100.58 MHz, 31P at 161.90 MHz). 1H and 13C{1H} NMR chemical
shifts are reported using tetramethylsilane (TMS) as the internal
standard and 31P{1H} spectra were measured relative to H3PO4 as
the external standard. Infrared (IR) spectra were determined using
a Perkin–Elmer Spectrum One FT-IR spectrometer and were re-
corded using KBr pellets. Elemental analyses (C, H and N) were re-
corded on a Thermo Flash 1112 Series CHNS-O Analyser. Mass
spectrometry was carried out at the University of Stellenbosch on
a Waters API Quattro Micro triple quadrupole mass spectrometer.
Data were recorded using Electrospray Ionisation (ESI) mass spec-
trometry in the negative or positive modes. Melting points are cor-
rected and were determined on a Reichert Thermovar hot stage
microscope.
2.3. Synthesis of ethylene- (1–3) and phenylene-bridged (4–6)
dithiosemicarbazone ligands
General procedure: Either ethane-1,2-dithiosemicarbazide or
benzene-1,4-dithiosemicarbazide (1 equiv.) was dissolved in N,N-
dimethylformamide (20 mL) at 120 C. Upon complete dissolution,
the appropriate salicylaldehyde (2 equiv.), dissolved in DMF
(5 mL), was then added dropwise to the solution. The mixture
was stirred at 120 C for 5 h. Cold water was added to induce pre-
cipitation of the product in all cases. The resulting precipitate was
collected by ﬁltration and washed with cold water. The products
were dried in the oven at 110 C.
Compound 1 was prepared from ethane-1,2-dithiosemicarbaz-
ide (0.205 g, 0.985 mmol) and salicylaldehyde (0.210 mL,
1.97 mmol). Compound 1 was isolated as a light yellow powder.
Yield 0.307 g (74.7%). M.p. 223–227 C. Anal. Calc. for
C18H20N6S2O2: C, 51.90; H, 4.84; N, 20.17; S, 15.40. Found: C,
51.58; H, 5.11; N, 20.30; S, 16.06%. mmax/cm1 1618 (C@N). 1H
NMR (400 MHz, DMSO-d6, 25 C): d = 3.83 (4H, s, CH2), 6.77 (2H,
t, J = 7.72, Ar), 6.85 (2H, d, J = 8.17, Ar), 7.19 (2H, t, J = 7.53, Ar),
7.96 (2H, d, J = 7.73, Ar), 8.39 (2H, s, CH@N), 8.57 (2H, s, NHCH2),
9.86 (2H, s, OH), 11.47 (2H, s, C@NNH) ppm. 13C{1H} NMR
(75 MHz, DMSO-d6, 25 C): d = 43.32, 115.85, 118.99, 120.22,
126.61, 130.78, 139.64, 156.22, 177.23 ppm. MS ESI: m/z 415
(100%, [MH]+).
Compound 2 was prepared from ethane-1,2-dithiosemicarbaz-
ide (0.205 g, 0.986 mmol) and 2-hydroxy-3-methoxy-benzalde-
hyde (0.300 g, 1.97 mmol). The product was isolated as a pale
yellow powder. Yield 0.441 g (93.7%). M.p. 245–249 C. Anal. Calc.
for C20H24N6S2O4: C, 50.40; H, 5.08; N, 17.63; S, 13.46. Found: C,
49.99; H, 5.34; N, 17.36; S, 12.92%. mmax/cm1 1671 (CN). 1H
NMR (400 MHz, DMSO-d6, 25 C): d = 3.80 (6H, s, OMe), 3.83 (4H,
s, CH2), 6.73 (2H, t, J = 7.98, Ar), 6.94 (2H, d, J = 7.03, Ar), 7.58
(2H, d, J = 7.86, Ar), 8.41 (2H, s, CH@N), 8.56 (2H, s, NHCH2), 9.12
(2H, s, OH), 11.5 (2H, s, CH@NNH) ppm. 13C{1H} NMR (75 MHz,
DMSO-d6, 25 C): d = 43.32, 55.79, 112.84, 118.14, 118.74, 120.68,
139.44, 145.8, 147.78, 177.23 ppm. MS ESI: m/z 475 (100%,
[MH]+).
Compound 3 was prepared from ethane-1,2-dithiosemicarbaz-
ide (0.204 g, 0.979 mmol) and 3-tert-butyl-salicylaldehyde
(0.340 mL 1.96 mmol). Compound 3 was isolated as a pale yellow
powder. Yield 0.365 g (73.9%). M.p. 226–230 C. Anal. Calc.
for C24H36N6S2O2: C, 57.11; H, 7.19; N, 16.65; S, 12.71. Found:
C, 57.55; H, 6.88; N, 16.44; S, 12.80%. mmax/cm1 1599 (C@N).
1H NMR (400 MHz, DMSO-d6, 25 C): d = 1.39 (18H, s, tBu),
3.84 (4H, s, CH2), 6.84 (2H, t, J = 7.67, Ar), 7.24 (4H, m, Ar), 8.29
(2H, s, CH@N), 8.60 (2H, s, NHCH2), 9.96 (2H, s, OH), 11.41
(2H, s, CH@N–NH) ppm. 13C{1H} NMR (100 MHz, DMSO-d6,
25 C): d = 30.06, 35.15, 44.33, 119.52, 120.02, 129.14, 129.99,
137.49, 147.66, 156.00, 177.88 ppm. MS ESI: m/z 529 (100%,
[M+Na]+).
Compound 4 was synthesized from benzene-1,4-dithiosemicar-
bazide (0.205 g, 0.800 mmol) and salicylaldehyde (0.171 mL,
1.60 mmol). The precipitate was isolated as a pale yellow powder.
Yield 0.323 g (86.9%). M.p. 233–241 C. Anal. Calc. for
C22H20N6S2O2: C, 56.88; H, 4.34; N, 18.09; S, 13.80. Found: C,
56.32; H, 4.36; N, 17.63; S, 13.41%. mmax/cm1 1622 (C@N). 1H
NMR (300 MHz, DMSO-d6, 25 C): d = 6.85 (4H, m, Ar), 7.23 (2H,
t, J = 8.46, Ar), 7.55 (4H, s, Ph), 8.02 (2H, d, J = 7.78, Ar), 8.49 (2H,
s, CH@N), 9.89 (2H, s, OH), 9.93 (2H, s, S@CNHPh), 11.64 (2H, s,
CH@NNH) ppm. 13C{1H} NMR (75 MHz, DMSO-d6, 25 C):
d = 116.03, 119.16, 120.15, 124.88, 127.15, 131.16, 136.02,
140.45, 156.47, 175.72 ppm. MS ESI: m/z 465 (100%, [M+H]+).
Compound 5 was prepared using benzene-1,4-dithiosemicar-
bazide (0.206 g, 0.800 mmol) and 2-hydroxy-3-methoxy-benzalde-
hyde (0.245 g, 1.60 mmol). Compound 5 was isolated as a pale
yellow powder. Yield 0.273 g (65.1%). M.p. 233–236 C. Anal. Calc.
for C24H24N6S2O4: C, 54.95; H, 4.61; N, 16.02; S, 12.22. Found: C,
54.10; H, 4.65; N, 16.84; S, 12.94%. mmax/cm1 1659 (CN). 1H
NMR (300 MHz, DMSO-d6, 25 C): d = 3.83 (6H, s, OMe), 6.81 (2H,
t, J = 7.96, Ar), 6.99 (2H, d, J = 8.06, Ar), 7.48–7.66 (2H, m, Ar),
7.57 (4H, s, Ph), 8.52 (2H, s, CH@N), 9.82 (2H, m, OH), 9.93 (2H,
m, S@CNHPh), 11.66 (2H, s, CH@NNH) ppm. 13C{1H} NMR
(75 MHz, DMSO-d6, 25 C): d = 55.89, 113.16, 118.58, 118.86,
120.58, 124.99, 135.99, 140.18, 146.15, 147.88, 175.70 ppm. MS
ESI: m/z 525 (10%, [M+H]+); 391 (100%, [MC8H6O2]+).
Compound 6 was prepared using benzene-1,4-dithiosemicar-
bazide (0.153 g, 0.596 mmol) and 3-tert-butyl-salicylaldehyde
(0.204 mL, 1.19 mmol) in a DMF/EtOH solution. Compound 6 was
isolated as a pale yellow powder. Yield 0.098 g (28.5%). M.p.
288–292 C. Anal. Calc. for C30H36N6S2O2: C, 62.47; H, 6.29; N,
14.57; S, 11.12. Found: C, 62.19; H, 6.57; N, 14.55; S, 11.05%.
mmax/cm1 1667 (CN). 1H NMR (300 MHz, DMSO-d6; 25 C):
d = 1.33 (18H, m, tBu), 6.95 (2H, m, Ar), 7.75–7.21 (8H, m, Ar/Ph),
8.39 (2H, s, CH@N), 10.07 (4H, m, OH/NHPh), 11.58 (2H, m,
CH@NNH) ppm. 13C{1H} NMR (75 MHz, DMSO-d6; 25 C):
d = 29.17, 34.42, 118.75, 119.24, 121.09, 125.10, 128.50, 129.43,
136.857, 147.47, 155.42, 176.40 ppm. MS ESI: m/z 577 (100%,
[M+H]+).
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Fig. 1. Example of a dithiosemicarbazone and a bis(thiosemicarbazone) (X = ali-
phatic or aromatic spacer).
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2.4. Synthesis of binuclear palladium complexes (7–12)
2.4.1. General procedure
A heated solution (50 C) of either ethane-1,2-dithiosemicar-
bazone or benzene-1,4-dithiosemicarbazone (1 equiv.) in ethanol
(50 mL) was stirred under nitrogen. To the mixture was added,
1 equiv. of triethylamine. Upon dissolution of the dithiosemicar-
bazone, Pd(PPh3)2Cl2 (2 equiv.) was added resulting in an orange
reaction mixture. The reaction mixture was reﬂuxed for 6 h and
then cooled to room temperature. The resulting orange precipitate
was ﬁltered, washed with ethanol and dried in vacuo.
2.4.2. Compound 7
Compound 1 (0.103 g, 0.247 mmol), triethylamine (0.035 mL)
and Pd(PPh3)2Cl2 (0.347 g, 0.494 mmol) were reﬂuxed in ethanol.
The product was obtained as a light orange powder. Yield 0.213 g
(74.9%). M.p. 274–283 C (with decomposition). Anal. Calc. for
C54H46N6S2P2O2Pd2: C, 56.40; H, 4.03; N, 7.31; S, 5.58. Found: C,
56.08; H, 4.04; N, 7.02; S, 5.09%. mmax/cm1 1599 (C@N). 1H NMR
(300 MHz, DMSO-d6, 25 C): d = 3.36 (4H, s, CH2), 6.55 (4H, m,
Ar), 6.98 (2H, s, NHCH2), 7.18 (2H, t, J = 8.78, Ar), 7.38 (2H, d,
J = 7.80, Ar), 7.39–7.68 (30H, m, PPh3), 8.33 (2H, d, J = 13.98,
CH@N) ppm. 13C{1H} NMR (75 MHz, DMSO-d6, 25 C): d = 44.99,
114.31, 117.77, 119.81, 128.38–134.02, 148.82, 161.47,
169.16 ppm. 31P NMR (120 MHz, DMSO-d6, 25 C): d = 25.58 (2P,
s, PPh3) ppm. MS ESI: m/z 1151 (100%, [M+H]+).
2.4.3. Compound 8
Compound 2 (0.119 g, 0.249 mmol), triethylamine (0.035 mL)
and Pd(PPh3)2Cl2 (0.350 g, 0.498 mmol) were reﬂuxed in ethanol.
The product was isolated as an orange powder. Yield 0.286 g
(94.9%). M.p. 264–271 C (with decomposition). Anal. Calc. for
C56H50N6S2P2O4Pd2: C, 55.58; H, 4.17; N, 6.90; S, 5.30. Found: C,
56.00; H, 4.49; N, 6.36; S, 5.30%. mmax/cm1 1598 (C@N). 1H NMR
(300 MHz, DMSO-d6, 25 C): d = (OMe signal suppressed by H2O),
3.59 (4H, s, CH2), 5.72 (2H, s, NHCH2), 6.52 (2H, t, J = 7.41, Ar),
6.86 (2H, m, Ar), 7.10 (2H, d, J = 7.41, Ar), 7.20–7.88 (30H, m,
PPh3), 8.27 (2H, d, J = 14.01, CH@N) ppm. 13C{1H} NMR (75 MHz,
DMSO-d6, 25 C): d = 44.97, 55.87, 113.52, 114.24, 117.42, 125.85,
128.13–134.14, 149.04, 150.68 152.87, 168.83 ppm. 31P NMR
(120 MHz, DMSO-d6, 25 C): d = 19.61 (2P, s, PPh3) ppm. MS ESI:
m/z 1210 (20%, [M+H]+); 279 (100%, [MC8H6N2SO2Pd(PPh3)2]+).
2.4.4. Compound 9
Compound 3 (0.122 g, 0.243 mmol), triethylamine (0.034 mL)
and Pd(PPh3)2Cl2 (0.341 g, 0.485 mmol) were reﬂuxed in ethanol.
This yielded the product 9 as an orange powder. Yield 0.221 g
(72.1%). M.p. 258–262 C (with decomposition). Anal. Calc. for
C62H62N6S2P2O2Pd2: C, 59.00; H, 4.95; N, 6.66; S, 5.08. Found: C,
60.21; H, 5.32; N, 5.89; S, 4.94%. mmax/cm1 1593 (C@N). 1H NMR
(300 MHz, CDCl3, 25 C): d = 0.75 (18H, s, tBu), 3.38 (2H, s, CH2),
5.08 (2H, s, NHCH2), 6.56 (2H, t, J = 7.57, Ar), 7.19–7.79 (34H, m,
PPh3, Ar), 8.28 (2H, d, J = 14.19, CH@N) ppm. 13C{1H} NMR
(75 MHz, DMSO-d6, 25 C): d = 30.08, 34.95, 45.91, 114.39,
118.88, 128–135, 139.92, 151.07, 161.95 ppm. 31P NMR
(120 MHz, CDCl3, 25 C): d = 24.35 (2P, s, PPh3) ppm. MS ESI: m/z
1263 (50%, [M+H]+); 675 (100%, [MC11H13N2SOPdPPh3]+).
2.4.5. Compound 10
Compound 4 (0.100 g, 0.210 mmol), triethylamine (0.031 mL)
and Pd(PPh3)2Cl2 (0.312 g, 0.430 mmol) were reﬂuxed in dry etha-
nol. Compound 10 was isolated as an orange powder. Yield 0.239 g
(95.1%). M.p.: does not melt below 300 C. Anal. Calc. for
C58H46N6S2P2O2Pd2: C, 58.15; H, 3.87; N, 7.02; S, 5.35. Found: C,
57.45; H, 3.83; N, 6.96; S, 5.50%. mmax/cm1 1598 (CN). 1H NMR
(300 MHz, DMSO-d6, 25 C): d = 6.60 (4H, m, Ar), 7.21 (4H, m, Ar),
7.57–7.71 (34H, m, PPh3, Ph), 8.63 (2H, d, J = 13.78, CH@N), 9.26
(2H, s, NHPh) ppm. 31P NMR (120 MHz, DMSO-d6, 25 C):
d = 25.61 (2P, s, PPh3) ppm.
2.4.6. Compound 11
Compound 5 0.113 g, 0.210 mmol), triethylamine (0.030 mL)
and Pd(PPh3)2Cl2 (0.301 g, 0.430 mmol) were reﬂuxed in ethanol.
A dark orange powder (11) was isolated. Yield 0.241 g (91.3%).
M.p.: does not melt below 300 C. Anal. Calc. for C60H50N6S2-
P2O4Pd2: C, 57.28; H, 4.01; N, 6.68; S, 5.10. Found: C, 57.62; H,
3.84; N, 6.84; S, 5.21%. mmax/cm1 1589 (C@N). 1H NMR
(300 MHz, DMSO-d6, 25 C): d = 3.63 (6H, s, OMe), 6.56 (2H, t,
J = 7.81, Ar), 6.91 (2H, d, J = 7.70, Ar), 7.16 (2H, d, J = 8.24, Ar),
7.76–7.49 (34H, m, PPh3, Ar), 8.61 (2H, d, J = 13.85, CH@N), 9.23
(2H, s, NHPh) ppm. 31P NMR (120 MHz, DMSO-d6, 25 C): d =
19.73 (2P, s, PPh3) ppm.
2.4.7. Compound 12
Compound 6 (0.126 g, 0.219 mmol), triethylamine (0.031 mL)
and Pd(PPh3)2Cl2 (0.307 g, 0.438 mmol) were reﬂuxed in ethanol.
A dark orange powder was isolated. Yield 0.227 g (79.12%). M.p.:
does not melt below 300 C. Anal. Calc. for C66H62N6S2P2O2Pd2: C,
60.50; H, 4.77; N, 6.42; S, 4.89. Found: C, 60.45; H, 4.91; N, 6.88;
S, 4.95%. mmax/cm1 1593 (C@N). 1H NMR (300 MHz, DMSO-d6,
25 C): d = 0.69 (18H, s, tBu), 6.53 (2H, t, J = 7.56, Ar), 7.08–7.86
(38H, m, Ar/Ph), 8.59 (2H, d, J = 14.05, CH@N), 9.12 (2H, s,
NHPh) ppm. 13C{1H} NMR (100 MHz, CDCl3-d, 25 C): d = 29.4,
34.8, 114.1, 118.1, 119.4, 128.4–134.8, 140.3, 153.2, 162.4,
164.8 ppm. 31P NMR (120 MHz, DMSO-d6, 25 C): d = 25.67 (2P, s,
PPh3) ppm. MS ESI: m/z 1311 (10%, [M+H]+).
2.5. X-ray crystallography
Crystals suitable for X-ray diffraction study for 72 DMSO and
114 DMSOwere grown from concentrated DMSO solutions of com-
plexes 7 and 11, respectively. An orange crystal of 72 DMSO was
mounted on a Stoe Image Plate Diffraction system equipped with
a / circle goniometer, using Mo Ka graphite monochromated radi-
ation (k = 0.71073 Å) with / range 0–200, increment of 1.2,
Dmax  Dmin = 12.45–0.81 Å.Whereas a yellow crystal of 114 DMSO
was mounted on a Nonius Kappa-CCD diffractometer using graph-
ite monochromated Mo Ka radiation (k = 0.71073 Å), equipped
with an Oxford Cryostream cooling system. Data were evaluated
using the Bruker Nonius ‘‘Collect” program and was scaled and re-
duced using DENZO-SMN software. Both structures were solved by
direct methods using the program SHELXS-97 [28]. The reﬁnement
and all further calculations were carried out using SHELXL-97 (see Ta-
ble 1) [29]. The hydrogen atoms were included in calculated posi-
tions and treated as riding atoms using the SHELXL default
parameters. All non-H atoms were reﬁned anisotropically, using
weighted full-matrix least-square on F2. Figs. 2 and 3 were drawn
with ORTEP [30]. Packing diagram (Fig. 4) was produced using the
program PovRay [31] and the graphic interface X-seed [32].
2.6. Cytotoxic assay
The dithiosemicarbazone ligandswere evaluated for their in vitro
anticancer activity against three oesophageal cancer cell lines,
WHCO1, WHCO5 and WHCO6, derived from biopsies of primary
oesophageal squamous cell carcinomas [33] and kindly provided
by Professor Rob Veale (University of Witwatersrand, South Africa).
IC50 determinations were carried out using the MTT assay. Brieﬂy,
3000 cells were seeded per well in 96-well plates. Cells were incu-
bated at 37 C under 5% CO2 (24 h), afterwhich aqueous DMSO solu-
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tions of each compound (10 lL, with a constant ﬁnal concentration
of DMSO = 0.2%) were plated at various concentrations. After 48 h
incubation, observations were made, and MTT (10 lL) solution
added to each well. After a further 4 h incubation, solubilization
solution (100 lL)was added to eachwell, and plateswere incubated
overnight. Plates were read at 595 nm on a BioTek microplate
reader.
3. Results and discussion
3.1. Synthesis and characterization of dithiosemicarbazone ligands (1–6)
A series of ethylene- and phenylene-bridged salicylaldimine
dithiosemicarbazones were synthesized using a procedure similar
to that previously reported by Scovill [26] and Dilworth et al.
[23]. Our initial attempts at preparing dithiosemicarbazones via
amination reactions of the appropriate aryl thiosemicarbazide with
either ethylenediamine or phenylenediamine proved to be unsuc-
cessful, despite reﬂuxing for extended periods or using microwave-
assisted techniques.
Two different routes were followed to prepare the bridged
dithiosemicarbazone ligands. The synthesis of the ethylene-
bridged dithiosemicarbazone ligands via the known reaction of
hydrazine with a diacid precursor produced ethane-1,2-dithiose-
micarbazide [26]. Benzene-1,4-dithiosemicarbazide was obtained
using a simple one-step procedure via the reaction of hydrazine
with phenylene diisothiocyanate as the starting precursor [23].
Subsequent Schiff-base condensation of either ethane-1,2-dithi-
osemicarbazide or benzene-1,4-dithiosemicarbazide with salicyl-
aldehyde, 2-hydroxy-3-methoxy benzaldehyde or 3-tert-butyl
salicylaldehyde afforded the ethylene-bridged (1–3) and pheny-
lene-bridged (4–6) dithiosemicarbazones (Scheme 1).
The ethylene- and phenylene-linked dithiosemicarbazone li-
gands (1–6) were isolated by precipitation in water, as pale yellow
Fig. 2. Molecular structure of complex 7 showing ellipsoids at the 50% probability level with hydrogen atoms and solvent molecules omitted for clarity.
Fig. 3. Molecular structure of complex 11 showing ellipsoids at the 50% probability level with hydrogen atoms and solvent molecules omitted for clarity.
Fig. 4. Crystal packing arrangement of compound 114 DMSO.
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powders in varying yields (65–94%) and the proposed structures
are supported by analytical and spectroscopic data.
The structures of dithiosemicarbazone ligands 1–6 were con-
ﬁrmed by 1H, 13C, COSY and HSQC NMR spectroscopy. The 1H
NMR spectra of the products show a singlet in the range d 8.3–
8.5 ppm, assigned to the imine protons. A characteristic singlet is
observed for the ethylene (1–3) and phenylene protons (4–6) at
about d 3.83 ppm and d 7.55 ppm respectively, due to the symmet-
rical nature of the dithiosemicarbazone compounds. Generally, the
phenylene-bridged thiosemicarbazone ligands (4–6) show similar
trends in the NMR spectra to those of the ethylene-bridged ligands
(1–3). 13C{1H} NMR spectral assignments were made with the aid
of 2D Heteronuclear Single Quantum Coherence (HSQC) spectros-
copy. Peaks assigned to the carbons of the aromatic groups are ob-
served in the region of d 115–156 ppm. A peak assigned to the
imine carbon is observed around d 140 ppm.
Further information on the integrity of the ligands was gleaned
from infrared spectroscopic techniques. The IR spectra of the Schiff
base dithiosemicarbazone ligands showed a strong absorption
band for the imine functionality at around 1622–1598 cm1. The
absorption band at 850–820 cm1 in the free ligand may be as-
signed to the thioamide vibration m(C@S), indicating that the ligands
exist in the thione form.
The ESI mass spectra for compounds 1–2, 4–6 recorded in the
negative mode generally showed a 100% relative intensity peak
(base peak) due to the [MH]+ ion. For compound 3, however, a
base peak at m/z 527 is observed in the ESI spectrum, attributed
to the presence of a sodium adduct, [M+Na]+.
3.2. Binuclear dithiosemicarbazone salicylaldiminato palladium(II)
complexes (7–12)
For polydentate ligands such as compounds 1–6, various bond-
ing modes are possible depending on the ligand to metal ratio. In
an attempt to prepare binuclear palladium dithiosemicarbazones,
the palladium(II) complexes (7–12) were selectively prepared by
reacting the corresponding dithiosemicarbazone ligands (1–6)
with Pd(PPh3)2Cl2 in a 1:2 stoichiometric ratio (ligand:metal),
giving rise to binuclear palladium complexes (Scheme 2). The
synthesis of the complexes was performed using methodologies
similar to those reported previously by Halder et al. [34].
The palladium complexes (7–12) are isolated as orange pow-
ders in high yields (75–95%). They are air-stable as solids and in
solution. The ethylene-bridged palladium(II) complexes (7–9) are
readily soluble in polar solvents such as DMSO, chlorinated sol-
vents (CH2Cl2), and are sparingly soluble in alcoholic solvents.
The phenylene-bridged palladium(II) complexes (10, 11), however,
are found to be far less soluble than their ethylene-bridged coun-
terparts. Surprisingly, complex 12 shows greater solubility than
the analogous phenylene-bridged palladium complexes. The bime-
tallic complexes (7–12) have been characterized by elemental
analyses, 1H, 13C, 31P NMR and IR spectroscopies, and ESI-MS.
3.2.1. NMR spectroscopy
The ethylene- and phenylene-bridged palladium complexes dis-
play in the 1H NMR spectra the expected singlet for the ethylene
and phenylene protons at around d 3.38 ppm and d 7.47–
7.71 ppm, respectively, due to the symmetrical nature of the com-
pounds. Evidence for the formation of palladium complexes is seen
by the notable shift of the signal for the imine proton, suggesting
coordination of palladium to the imine nitrogen. Splitting of the
imine signal into a doublet in the region at around d 8.33 ppm is
observed and is attributed to coupling of the imine proton to the
nucleus of the phosphorus atom (4JP–H = 13.98 Hz). The disappear-
ance of the signal for the hydroxyl proton, together with the ob-
served shift of the imine proton observed in the 1H NMR
spectrum, provides good evidence of coordination of palladium,
resulting in a six-membered ring with N,O donor atoms. In addi-
tion to this, the disappearance of the signal assigned to the hydra-
zinic proton adjacent to the imine group, conﬁrms the formation of
a second imine bond upon coordination of palladium, suggesting
that the sulfur atom coordinates in the thiolate form rather than
the thione form, thus forming a ﬁve-membered chelate ring (N, S
donor atoms). The phenylene-bridged complexes (10, 11) were
difﬁcult to characterize using NMR spectroscopic techniques due
to their low solubility in most deuterated solvents, including
DMSO-d6. The 1H NMR spectrum of compound 10, speciﬁcally,
was not well-resolved, but a trend similar to that of the ethyl-
ene-bridged complex 7 was discernible and assignments made
on that basis.
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All the expected peaks are observed in the 13C{1H} NMR spectra
for compounds 7–12. It was not possible to obtain 13C NMR spec-
tral data for the phenylene-bridged complexes (10, 11), even at
elevated temperatures, due to the poor solubility of these com-
plexes. A sharp singlet is observed in the 31P{1H} NMR spectra
for each palladium-PPh3 complex in the region around d 25.6 ppm.
3.2.2. Infrared spectroscopy
Infrared spectroscopy is a useful diagnostic tool to conﬁrm
coordination of palladium. The IR spectra of the palladium com-
plexes 7–12 show a band of medium to strong intensity within
1599–1589 cm1, attributed to the C@N–N@C fragment of the
coordinated dithiosemicarbazone ligand. The shift of the imine
absorption band (mC–N) in the free ligand (1600–1671 cm1) to low-
er wavenumbers in the metal complexes, is indicative of the coor-
dination of palladium to the imine nitrogen. The IR spectra of the
[Pd(L)(PPh3)] (L = dithiosemicarbazone) complexes (7–12) gener-
ally show many vibrations of different intensities in the 1600–
400 cm1 region and are qualitatively very similar. Three diagnos-
tic bands for the PPh3 ligands near 533, 694 and 743 cm1 are ob-
served for all the complexes. The characteristic bands due to the
m(P–C) vibration are also observed in the region 1098–1095 cm1,
indicative of the presence of coordinated PPh3 in the complexes
[35–37]. Bands involving the C@S functional group are often difﬁ-
cult to assign. Coordination by sulfur induces changes in position
and intensity of the bands and the proximity of the phenyl ring
bands (triphenylphosphine ligand) makes it difﬁcult to clearly as-
sign the vibration modes. The disappearance of the C@S band ob-
served in the free ligand, correlates with the loss of double-bond
character upon deprotonation of the NH group. This supports the
lengthening of the C–S bond which we observe in representative
molecular structures. For thiosemicarbazones bonding in the thio-
late form, the C@S band generally shifts to lower energy in the re-
gion 820–790 cm1. However, no deﬁnite assignment of each
individual band to a speciﬁc vibration could be made.
3.2.3. Mass spectrometry
ESI-mass spectrometry further conﬁrmed the integrity of the
binuclear complexes. The ESI spectrum of compound 7 displays a
base peak for the complex in its protonated form [M+H]+ at m/z
1151. The spectrum of compound 8 reveals a peak at m/z 1210
for the [M+H]+ ion of 20% intensity. A base peak at m/z 279, ac-
counts for the fragment, [MC8H6N2SO2Pd(PPh3)2]+. The spectrum
of compound 9 displays a peak of 50% intensity for the protonated
complex at m/z 1263. In addition to this, a base peak at m/z 675,
corresponds to the fragment, [MC11H13N2SOPdPPh3]+. The poor
solubility of complexes 10 and 11 precluded an accurate determi-
nation by ESI-mass spectrometry.
3.3. Solid-state structures of complexes 7 and 11
To further conﬁrm the mode of coordination of these palladium
dithiosemicarbazone complexes, molecular structures of one
member of each group (ethylene- and phenylene-bridged) have
been determined using single-crystal X-ray crystallography. Single
crystals of compounds 7 and 11 were obtained from concentrated
dimethyl sulfoxide solutions. Figs. 2 and 3 show the molecular
structures of 7 and 11, respectively, while Table 2 gives selected
bond lengths and angles.
The crystal structures show that the dithiosemicarbazone li-
gands coordinate to each palladium center via the phenolic oxygen,
imine nitrogen and sulfur atoms in a square-planar geometry, as
the spectroscopic data suggests. These two structures conﬁrm that
the fourth coordination site is occupied by a triphenylphosphine li-
gand. Both complexes show that the dithiosemicarbazone ligands
(1 and 5) are coordinated to palladium in the expected tridentate
(O–N–S) fashion on either side of the dithiosemicarbazone. The
structures show the formation of six- and ﬁve-membered chelate
rings upon coordination, thus imposing distortion around the
square-planar metal centers. Indeed, the structures display O(1)–
Pd(1)–N(1) and N(1)–Pd(1)–S(1) bite angles of 93.1(2) and
84.55(17) in 7 and of 92.15(12) and 84.03(10) in 11. In both, a
triphenylphosphine ligand is found trans to the nitrogen atomwith
Pd–P distances of 2.273(2) and 2.284(1) Å, respectively and with
O(1)–Pd(1)–P(1) and S(1)–Pd(1)–P(1) bite angles of 88.53(14)
and 93.91(7) in 7 and of 91.28(8) and 92.44(4) in 11. These
parameters are comparable to those in other trans P–N, S–O
square-planar palladium complexes [16]. In addition to this, it
can be seen that coordination of the dithiosemicarbazone sulfur
atoms occur via the thiolate form, rather than the thione form
(Figs. 2 and 3) due to the formation of a second imine bond
Table 1
Crystallographic data and structure reﬁnement parameters for complexes 72 DMSO
and 114 DMSO
72 DMSO 114 DMSO
Chemical formula C58H56N6O4P2Pd2S4 C68H74N6O8P2Pd2S6
Formula weight 1304.07 1570.43
Crystal system monoclinic monoclinic
Space group C 2/c P 21/n
Crystal colour and shape orange rod yellow needle
Crystal size 0.12  0.07  0.06 0.24  0.11  0.11
a (Å) 30.436(3) 10.4372(3)
b (Å) 10.0175(9) 14.8288(4)
c (Å) 18.732(2) 22.7294(5)
a () 90 90
b () 100.57(1) 100.526(1)
c () 90 90
V (Å3) 5614.3(9) 3458.7(2)
Z 4 2
T (K) 173(2) 173(2)
Dc (g cm3) 1.543 1.508
l (mm1) 0.899 0.806
Scan range () 4.28 < 2h < 52.42 3.30 < 2h < 50.84
Unique reﬂections 5553 6344
Reﬂections used [I > 2r(I)] 1533 5063
Rint 0.1920 0.0685
Final R indices [I > 2r(I)]a 0.0336, wR2 0.0488 0.0444, wR2 0.1096
R indices (all data) 0.1786, wR2 0.0734 0.0611, wR2 0.1194
Goodness-of-ﬁt (GOF) 0.478 1.051
Maximum, minimum Dq (e Å3) 0.524, 1.125 1.073, 0.906
a Structures were reﬁned on F2o: wR2 ¼ ½
P½wðF2o  F2c Þ2=
P
wðF2oÞ21=2, where
w1 ¼ ½PðF2oÞ þ ðaPÞ2 þ bP and P ¼ ½maxðF2o ;0Þ þ 2F2c =3
Table 2
Selected bond lengths (Å) and angles () for complexes 7 and 11.
7 11
Pd(1)–P(1) 2.273(2) Pd(1)–P(1) 2.284(1)
Pd(1)–S(1) 2.238(2) Pd(1)–S(1) 2.244(1)
Pd(1)–N(1) 2.028(5) Pd(1)–N(1) 2.018(3)
Pd(1)–O(1) 2.019(4) Pd(1)–O(1) 2.062(3)
N(1)–C(3) 1.284(8) N(1)–C(8) 1.296(5)
N(1)–N(2) 1.403(7) N(1)–N(2) 1.405(4)
N(2)–C(2) 1.311(7) N(2)–C(9) 1.300(5)
N(3)–C(2) 1.354(7) N(3)–C(9) 1.352(5)
N(3)–C(1) 1.455(8) N(3)–C(10) 1.413(5)
S(1)–C(2) 1.781(6) S(1)–C(9) 1.769(4)
P(1)–Pd(1)–S(1) 93.91(7) P(1)–Pd(1)–S(1) 92.44(4)
P(1)–Pd(1)–O(1) 88.53(14) P(1)–Pd(1)–O(1) 91.28(8)
P(1)–Pd(1)–N(1) 177.82(17) P(1)–Pd(1)–N(1) 175.64(10)
S(1)–Pd(1)–N(1) 84.55(17) S(1)–Pd(1)–N(1) 84.03(10)
S(1)–Pd(1)–O(1) 176.59(14) S(1)–Pd(1)–O(1) 175.68(8)
N(1)–Pd(1)–O(1) 93.1(2) N(1)–Pd(1)–O(1) 92.15(12)
C(1)–N(3)–C(2) 120.9(6) C(8)–N(1)–N(2) 114.1(3)
C(3)–N(1)–N(2) 115.8(5) N(1)–N(2)–C(9) 113.4(3)
N(1)–N(2)–C(2) 113.3(5) N(2)–C(9)–N(3) 121.8(3)
N(2)–C(2)–N(3) 121.4(6) C(9)–N(3)–C(10) 129.4(3)
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between C(2) and N(2) in 7 and between C(9) and N(2) in 11: Val-
ues of 1.311(7) and 1.300(5) Å being found for these bonds. This
further supports that these C–N bonds tend towards double-bond
character upon coordination. Comparison of these distances to
the C(2)–N(3) and C(9)–N(3) bond lengths, shows that the latter
are slightly longer (1.354(7) and 1.352(5) Å) and therefore tend to-
wards single-bond character. The C–S bond lengths are also found
to be consistent with coordination of sulfur in the thiolate form,
with values of 1.781(6) and 1.769(4) Å, respectively. A previous
study by Halder et al. [34] based on similar monomeric complexes,
reported C–S values of approximately 1.75 Å. In simple systems it
would be expected that a single C–S bond length would be approx-
imately 1.82 Å and a double C@S bond would exhibit a length of
1.56 Å. The length obtained in this study, therefore appears to be
close to the nature of a single C–S bond.
Further analysis of compound 11 reveals that the packing
arrangement displays four solvent molecules (DMSO) of crystalli-
sation per complex. This can be seen in the crystal lattice (Fig. 4).
Closer inspection of the packing arrangement of compound 11 re-
veals hydrogen bonding of two oxygen atoms of two of the DMSO
molecules to the secondary amine groups on either side of the
complex. This bonding is depicted by N(3)–H(3)N  O(1X) on the
right-hand side of the molecule. The same phenomenon is ob-
served on the adjacent end of the complex. In 7, in which two sym-
metry related molecules of DMSO crystallized per complex, the
oxygen atom of the solvent interacts with two adjacent hydrogen
atoms of the dithiosemicarbazone phenyl groups. The H  O dis-
tances are 2.686 and 2.691 Å and the C–H  O angles 122.9 and
124.4, respectively.
The information obtained herein therefore allowed us to further
conﬁrm the integrity of these molecules, in addition to their spec-
tral properties. We were therefore able to rationalize the modes of
coordination upon complexation of the metals.
3.4. Preliminary biological evaluation
The dithiosemicarbazone ligands were evaluated for their
in vitro anticancer activity against three oesophageal cancer cell
lines (WHCO1, WHCO5, WHCO6). All the dithiosemicarbazone li-
gands, with the exception of ligand 4, were cytotoxic in the cell
lines evaluated, showing IC50 values in the range 1.2–35 lM. The
fact that ligand 4 did not show any biological activity is ascribed
to the poor solubility of the ligand. The IC50 values calculated from
the dose-survival curves obtained after 48 h drug treatment from
the MTT assay, are shown in Table 3. Unfortunately, the cytotoxic-
ity of the palladium complexes could not be determined due to the
poor solubility of these complexes. Detailed studies are currently
underway to prepare more soluble palladium(II) salicylaldiminato
dithiosemicarbazone complexes.
4. Conclusions
In summary, we have shown that palladium(II) complexes of
salicylaldimine dithiosemicarbazones containing ethylene or
phenylene spacers may be prepared by the reaction of the new sal-
icylaldehyde-derived dithiosemicarbazone ligands (1–6) with
Pd(PPh3)2Cl2. This involved the preparation of ethylene- and phe-
nylene-bridged dithiosemicarbazides, that were condensed with
the appropriate salicylaldehydes, and thereafter metallated to give
rise to the new binuclear palladium complexes (7–12). For each
binuclear complex, it was found that in their solid-state structures,
both palladium centers coordinate in a tridentate (O–N–S) manner.
The expected square-planar geometry of the metal was also ob-
served. Preliminary in vitro antitumour activity of the dithiosemic-
arbazone ligands showed a moderate to good cytotoxicity for the
indicated cell lines. Biological activity of the palladium(II) com-
plexes of the dithiosemicarbazones could not be determined due
to poor solubility. Further investigations are underway to increase
the solubility of the palladium complexes and to explore their anti-
cancer activity.
Supplementary data
CCDC 723512 and 719351 contain the supplementary crystallo-
graphic data for 72 DMSO and 114 DMSO. These data can be
obtained free of charge via http://www.ccdc.cam.ac.uk/conts/
retrieving.html, or from the Cambridge Crystallographic Data
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-
336-033; or e-mail: deposit@ccdc.cam.ac.uk.
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